High Tide affiliate Remexian distributes record 7 tonnes medical cannabis in Germany quarter
PUBT · 05/06 10:04
Share
Listen to the news
- High Tide’s 51%-owned Remexian Pharma distributed 8 tonnes of medical cannabis into Germany in fiscal Q2 ended April 30, 2026, a quarterly record for the unit.
- Volume rose 21% sequentially, up 49% year over year, pointing to faster scaling in Europe’s largest medical cannabis market.
- Remexian holds more than 10% share of German medical cannabis import tonnage, positioning it to benefit from Germany’s 2025 medical cannabis imports of 201 tonnes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. High Tide Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605060600PR_NEWS_USPR_____CA52469) on May 06, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved